Novo Nordisk A/S is terminating a recently formed obesity-drug partnership with Hims & Hers Health Inc. that had been touted ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass ...

By Bhanvi Satija (Reuters) -Treatments designed to help patients preserve muscle while losing weight with popular obesity ...

Discover the future of Bartell Drugs as it transitions to a new identity while maintaining its community spirit.

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

Cholesterol-lowering medicines are some of the most commonly prescribed, effective drugs. Influencers on TikTok have other ...

The prosecution is close to resting its case in Sean “Diddy” Combs’s sex trafficking trial as ex-assistant Brendan Paul ...